Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-Dose Depot Triptorelin vs Reduced-Dose Daily Buserelin for ICSI/ET
NCT00461916Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triptorelin in infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Number of retrieved oocytes. Started May 2005; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00461916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461916.